Skip to main content
. 2011 Aug 26;66A(12):1286–1299. doi: 10.1093/gerona/glr125

Table 2.

End-of-Life Pathology of Tg(TRX1)+/0 Mice

WT Tg(TRX1)+/0
Neoplasm 25 (58.1%) 30 (73.2%)
    Lymphoma 20 (46.5%) 26 (63.4%)
    Hemangioma 2 2
    Others 3 2
Nonneoplasm 18 (41.9%) 11 (26.8%)
    Glomerulonephritis 8 6
    Others 10 5
Total 43 41

Note: WT = wild type.